PROM1 and neoplasm: CD133 has been shown to be a marker of a liver CSC subset, and CD133+ HCC cells are well known for their role in frequent relapse, drug resistance, tumor initiation, sustained self-renewal, differentiation and phenocopying of the original tumor [4–6].